Background Hyperimmune immunoglobulin (hIVIG) contains polyclonal antibodies, which
can be prepared from large amounts of pooled convalescent plasma or prepared from …

Coronaviruses (CoVs) are a group of viruses from the family Coronaviridae that can infect
humans and animals, causing mild to severe diseases. The ongoing pandemic of severe …

Summary COVID-19 convalescent plasmas (CCPs) are chosen for plasma therapy based on
neutralizing titers and anti-Spike immunoglobulin levels. However, CCP characteristics that …

The collection and clinical use of COVID-19 convalescent plasma (CCP) as a therapy for
COVID-19 infection is under development and early use in many centers worldwide. We …

Background: The COVID-19 pandemic, caused by a novel coronavirus termed SARS-CoV-2,
has spread quickly worldwide. Convalescent plasma (CP) obtained from patients following …

Background With the recent approval of COVID‐19 vaccines, recovered COVID‐19 subjects
who are vaccinated may be ideal candidates to donate COVID‐19 convalescent plasma …

Passive immunization with polyclonal hyper immunoglobulin (HIG) therapy represents a
proven strategy by transferring immunoglobulins to patients to confer immediate protection …

Since December 2019, the coronavirus disease 2019 (COVID-19) caused by the Severe
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has spread throughout China as …

Objectives Coronaviruses are globally emerging viruses that threaten our health care
systems and have become a popular pandemic around the world. This causes a sudden rise …

Vaccination has been shown to stimulate remarkably high antibody levels in donors who
have recovered from COVID-19. Our objective was to measure patient antibody levels …